UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PAI-1 and Diabetes: A Journey From the Bench to the Bedside

Diabetes care, 2012-10, Vol.35 (10), p.1961-1967

2012

Volltextzugriff (PDF)

Morphological and cytochemical determination of cell death by apoptosis

Histochemistry and cell biology, 2008-01, Vol.129 (1), p.33-43

2008

Volltextzugriff (PDF)

Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment

Biochemical and biophysical research communications, 2007-03, Vol.354 (3), p.700-706

2007

Volltextzugriff (PDF)

Profibrinolytic, Antithrombotic, and Antiinflammatory Effects of an Insulin-Sensitizing Strategy in Patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial

Circulation (New York, N.Y.), 2011-08, Vol.124 (6), p.695-703

2011

Volltextzugriff (PDF)

Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness

The Journal of clinical investigation, 2004-07, Vol.114 (1), p.104-111

2004

Volltextzugriff (PDF)

Increased plasma sphingosine-1-phosphate in obese individuals and its capacity to increase the expression of plasminogen activator inhibitor-1 in adipocytes

Coronary artery disease, 2013-12, Vol.24 (8), p.642-650

2013

Volltextzugriff (PDF)

The effect of plasminogen activator inhibitor type 1 on apoptosis

Thrombosis and haemostasis, 2008-12, Vol.100 (6), p.1037-1040

2008

Volltextzugriff (PDF)

Erythropoietin to Augment Myocardial Salvage Induced by Coronary Thrombolysis in Patients With ST Segment Elevation Acute Myocardial Infarction

The American journal of cardiology, 2009-10, Vol.104 (8), p.1035-1040

2009

Volltextzugriff (PDF)

Optimizing Cardiovascular Outcomes in Diabetes Mellitus

The American journal of medicine, 2007-09, Vol.120 (9), p.S3-S11

Sobel, Burton E., MD

2007

Volltextzugriff (PDF)

Posttranscriptional regulation of expression of plasminogen activator inhibitor type-1 by sphingosine 1-phosphate in HepG2 liver cells

Biochimica et biophysica acta, 2012-11, Vol.1819 (11-12), p.1132-1141

2012

Volltextzugriff (PDF)

Comparison of Plasminogen Activator Inhibitor-1, Tissue Type Plasminogen Activator Antigen, Fibrinogen, and D-Dimer Levels in Various Age Decades in Patients With Type 2 Diabetes Mellitus and Stable Coronary Artery Disease (from the BARI 2D Trial)

The American journal of cardiology, 2010, Vol.105 (1), p.17-24

2010

Volltextzugriff (PDF)

The Angiotensin Receptor Blocker, Azilsartan Medoxomil (TAK-491), Suppresses Vascular Wall Expression of Plasminogen Activator Inhibitor Type-I Protein Potentially Facilitating the Stabilization of Atherosclerotic Plaques

Journal of cardiovascular pharmacology, 2011-08, Vol.58 (2), p.143-148

2011

Volltextzugriff (PDF)

Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1

Arteriosclerosis, thrombosis, and vascular biology, 2006-08, Vol.26 (8), p.1777-1783

2006

Volltextzugriff (PDF)

Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis

Arteriosclerosis, thrombosis, and vascular biology, 2003-11, Vol.23 (11), p.1979-1989

2003

Volltextzugriff (PDF)

Conundrums in the combined use of anticoagulants and antiplatelet drugs

Circulation (New York, N.Y.), 2007-07, Vol.116 (3), p.305-315

2007

Volltextzugriff (PDF)

A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease

The New England journal of medicine, 2009-06, Vol.360 (24), p.2503-2515

2009

Volltextzugriff (PDF)

Inhibition of apoptosis and caspase-3 in vascular smooth muscle cells by plasminogen activator inhibitor type-1

Journal of cellular biochemistry, 2004-05, Vol.92 (1), p.178-188

2004

Volltextzugriff (PDF)

A Profibrotic Effect of Plasminogen Activator Inhibitor Type-1 (PAI-1) in the Heart

Experimental biology and medicine (Maywood, N.J.), 2009-03, Vol.234 (3), p.246-254

2009

Volltextzugriff (PDF)

Inhibition by fibrates of plasminogen activator inhibitor type-1 expression in human adipocytes and preadipocytes

Thrombosis and haemostasis, 2009-06, Vol.101 (6), p.1060-1069

2009

Volltextzugriff (PDF)

Posttranscriptional regulation of expression of plasminogen activator inhibitor type-1 by cAMP in HepG2 liver cells

Journal of biochemistry (Tokyo), 2011-12, Vol.150 (6), p.687-694

2011

Volltextzugriff (PDF)

Direct attenuation of plasminogen activator inhibitor type-1 expression in human adipose tissue by thiazolidinediones

Thrombosis and haemostasis, 2004-04, Vol.91 (4), p.674-682

2004

Volltextzugriff (PDF)

Meta-Analysis of Studies of Patients in the United Arab Emirates With ST-Elevation Myocardial Infarction Treated With Thrombolytic Agents

The American journal of cardiology, 2010-12, Vol.106 (12), p.1692-1695

2010

Volltextzugriff (PDF)

Endothelial dysfunction and inflammation after percutaneous coronary intervention

The American journal of cardiology, 2004-12, Vol.94 (11), p.1420-1423

2004

Volltextzugriff (PDF)

Increased expression of plasminogen activator inhibitor type-1 (PAI-1) in HEPG2 cells induced by insulin mediated by the 3'-untranslated region of the PAI-1 gene and its pharmacologic implications

Coronary artery disease, 2010-05, Vol.21 (3), p.144-150

2010

Volltextzugriff (PDF)

1 – 25 von 680

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(650)
Mit Volltextzugriff
(525)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(449)
Life Sciences & Biomedicine
(438)
Humans
(342)
Cardiovascular System & Cardiology
(310)
Cardiac & Cardiovascular Systems
(284)
Animals
(218)
Biological And Medical Sciences
(192)
Medical Sciences
(169)
Male
(148)
Female
(111)
Peripheral Vascular Disease
(103)
Middle Aged
(100)
Dogs
(92)
Time Factors
(71)
Aged
(69)
Cardiology. Vascular System
(68)
Heart
(64)
Adult
(63)
Creatine Kinase - Blood
(61)
Hematology
(59)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

PAI-1 and Diabetes: A Journey From the Bench to the Bedside

Morphological and cytochemical determination of cell death by apoptosis

Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment

Profibrinolytic, Antithrombotic, and Antiinflammatory Effects of an Insulin-Sensitizing Strategy in Patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial

Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness

Increased plasma sphingosine-1-phosphate in obese individuals and its capacity to increase the expression of plasminogen activator inhibitor-1 in adipocytes

The effect of plasminogen activator inhibitor type 1 on apoptosis

Erythropoietin to Augment Myocardial Salvage Induced by Coronary Thrombolysis in Patients With ST Segment Elevation Acute Myocardial Infarction

The temporal variability of dominant frequency and complex fractionated atrial electrograms constrains the validity of sequential mapping in human atrial fibrillation

Optimizing Cardiovascular Outcomes in Diabetes Mellitus

Posttranscriptional regulation of expression of plasminogen activator inhibitor type-1 by sphingosine 1-phosphate in HepG2 liver cells

Comparison of Plasminogen Activator Inhibitor-1, Tissue Type Plasminogen Activator Antigen, Fibrinogen, and D-Dimer Levels in Various Age Decades in Patients With Type 2 Diabetes Mellitus and Stable Coronary Artery Disease (from the BARI 2D Trial)

The Angiotensin Receptor Blocker, Azilsartan Medoxomil (TAK-491), Suppresses Vascular Wall Expression of Plasminogen Activator Inhibitor Type-I Protein Potentially Facilitating the Stabilization of Atherosclerotic Plaques

Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1

Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis

Conundrums in the combined use of anticoagulants and antiplatelet drugs

A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease

Inhibition of apoptosis and caspase-3 in vascular smooth muscle cells by plasminogen activator inhibitor type-1

A Profibrotic Effect of Plasminogen Activator Inhibitor Type-1 (PAI-1) in the Heart

Inhibition by fibrates of plasminogen activator inhibitor type-1 expression in human adipocytes and preadipocytes

Posttranscriptional regulation of expression of plasminogen activator inhibitor type-1 by cAMP in HepG2 liver cells

Direct attenuation of plasminogen activator inhibitor type-1 expression in human adipose tissue by thiazolidinediones

Meta-Analysis of Studies of Patients in the United Arab Emirates With ST-Elevation Myocardial Infarction Treated With Thrombolytic Agents

Endothelial dysfunction and inflammation after percutaneous coronary intervention

Increased expression of plasminogen activator inhibitor type-1 (PAI-1) in HEPG2 cells induced by insulin mediated by the 3'-untranslated region of the PAI-1 gene and its pharmacologic implications

Suchergebnisse filtern